Orexo AB (LTS:0H19)
kr 21.875 0 (0%) Market Cap: 607.29 Mil Enterprise Value: 1.09 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 57/100

Q4 2022 Orexo AB Earnings Call Transcript

Jan 26, 2023 / 01:00PM GMT
Release Date Price: kr20.78
Operator

Welcome to Orexo Q4 Report 2022. For the first part of the conference call, (Operator Instructions) Now I will hand the conference over to CEO, Nikolaj Sorensen. Please go ahead.

Nikolaj Sorensen;publ;President;CEO
Orexo AB

()-&

Thank you very much, and welcome to this fourth quarter and year-end presentation from Orexo. So the fourth quarter has been a quite eventful quarter from many aspects, both internally and externally. It's also been a quarter where we, on a quarter-by-quarter basis, have a decent headwind in terms of exchange rate development with the U.S. dollar weakening compared to the Swedish krona. But on an annual basis, the strengthening of the U.S. dollars have had a positive effect. And I will come back to that later.

So with me today, I have Fredrik Jarrsten, who will go through the financial results a little later in the presentation, and I will take you through the key achievements for the year and also give some business updates on U.S. pharma, Digital therapies and our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot